<DOC>
	<DOCNO>NCT00709358</DOCNO>
	<brief_summary>The primary purpose improve quicken microbial diagnosis severe infection , since one third case document blood culture adequate anti-infective therapy 48 hour reduce mortality morbidity . Our hypothesis detection microbial DNA blood real time PCR may increase number case diagnose bacteraemia fungemia shorten time positive result , provide information adequate anti-infectious therapy .</brief_summary>
	<brief_title>Diagnosis Septicaemia Detection Microbial DNA Blood Severe Infections</brief_title>
	<detailed_description>We evaluate advantage add molecular test microbial investigation usually do ( blood culture others ) case febrile neutropenia , suspicion infective endocarditis severe sepsis intensive care unit . This prospective study conduct 18 site ( 7 Paris area 11 France ) enrol 2000 patient 18 year . Sites randomized start 6-month period perform test 6-month period without test ( control time standard care ) . Primary outcome number patient document bacteraemia fungemia . Secondary outcome ( 1 ) number patient adequate anti-infective therapy long happen diagnosis , ( 2 ) mortality , ( 3 ) new complicate infection , ( 4 ) number investigation ( microbial non microbial ) do etiological diagnosis , global hospitalization cost . The advantage new test evaluate per protocol intend treat analysis . We hypothesize new test bring 15 % microbial diagnosis standard care . Consequently , accord number site interested study , 166 2500 patient enrol 480 750 patient febrile neutropenia , 1000 1500 patient severe sepsis Intensive Care Units ( ICU ) . Patients suspicion infective endocarditis evaluate number diagnosis true endocarditis accord Duke Criteria , time diagnosis . Health economic evaluation compare cost hospitalization , microbial investigation include new test , non clinical investigation consequence organization .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Endocarditis</mesh_term>
	<criteria>Age≥ 18 year Written sign date inform consent First time fever observe neutropenic patient Severe sepsis patient hospitalize ICU Suspicion infective endocarditis Microbial investigation Monday Friday Not affiliate Health Insurance ( social security ) Included another interventional trial test microbial DNA detection time `` without Septifast® '' Included another clinical trial clinician assume possible prescribe antiinfectious therapy adequately microbial detection blood Patient previously include protocol Sepsis microbial diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>bacteria</keyword>
	<keyword>fungi</keyword>
	<keyword>real time PCR</keyword>
	<keyword>adequate antimicrobial therapy</keyword>
	<keyword>microbial DNA</keyword>
	<keyword>microbial diagnosis</keyword>
</DOC>